Stay updated on Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision history updated: added v3.5.0 entry and removed v3.4.3 entry.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No study data or user-facing content changes.SummaryDifference0.1%

- Check55 days agoChange DetectedA new site revision tag was added (Revision: v3.4.2) and the previous revision tag (v3.4.1) along with a government funding operating-status notice were removed.SummaryDifference0.4%

- Check62 days agoChange DetectedA site-wide notice about government funding and NIH operations has been added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check69 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' notice, along with minor label updates such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedRemoved access to the Study Protocol and Statistical Analysis Plan PDF and other study documents. Additionally, related documentation references and MeSH terms were removed.SummaryDifference17%

Stay in the know with updates to Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance Trial in Hodgkin Lymphoma Clinical Trial page.